Vitamin E inhibits the high-fat diet promoted growth of established human prostate lncap tumors in nude mice

Journal of Urology

Volumn 161, Issue 5, 1999, Pages 1651-1654

  Fleshner, Neil ^a,b   Fair, William R ^a   Huryk, Robert ^a   Heston, W D W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; HUMAN; HUMAN CELL; LIPID DIET; MALE; MOUSE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; SURVIVAL RATE; TUMOR GROWTH; TUMOR VOLUME;

EID: 0032825154     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68998-7     Document Type: Article

References (20)

1. Parker, S. L., Tong, T., Bolden, B. A. and Wingo, P. A.: Cancer Statistics, 1997. CA Cancer J. Clin., 47: 1, 1997.
2. Dhom, G.: Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate. J. Cancer Res. Clin. Oncol., 106: 210, 1983.
3. Coffey, D. S.: Prostate cancer: an overview of an increasing dilemma. Cancer, 71: 880, 1993.
4. Pienta, K. J. and Esper, P. S.: Risk factors for prostate cancer. Ann. Int. Med., 118: 793, 1993.
5. Fair, W. R., Fleshner, N. E. and Heston, W. D.: Prostate cancer: a nutritional disease. Urology, 50: 1, 1997.
6. Wang, Y., Heston, W., Corr, J. and Fair, W.: Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. JNCI, 87: 1427, 1995.
7. Das, S.: Vitamin E in the genesis and prevention of cancer. Acta Oncol., 33: 615, 1994.
8. El Attar, T. M. and Lin, H. S.: Vitamin E succinate potentiates the inhibitory effect of prostaglandins on oral squamous carcinoma cell proliferation. Prostagl. Leukotr. Essent, F. A., 52: 69, 1995.
9. Schonberg, S. and Krokan, H. E.: The inhibitory effects of conjugated dienoic derivatives of linoleic acid on the growth of human tumor cells lines is in part due to increased lipid peroxidation. Anticancer Res., 15: 1241, 1995.
10. Vasavi, H., Thangaraju, M. and Sachdanandam, P.: Effects of alpha-tocopherol on lipid peroxidation and antioxidant system in fibrosarcoma bearing rats. Mol. Cell Biochem. 131: 125, 1994.
11. Shivapakur, H.: Inhibition of progression of aberrant crypt foci and colon tumor development by vitamin E and beta-carotene in rats on a high fat diet. Cancer Lett., 91: 125, 1995.
12. Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancers and other cancers in male smokers. NEJM, 330: 1029, 1994.
13. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H. and Chu, T. M.: LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809, 1983.
14. Gleave, M. E., Hsieh, J. T., Gao, C., von Eschenbach, A. C. and Chung, L. W.: Acceleration of human prostate growth in vivo by factors produced by prostate and bone fibroblast. Cancer Res., 51: 3753, 1991.
15. Hamalainen, E., Aldercreutz, H. and Pusak, P.: Diet and serum sex hormones in healthy men. J. Steroid Biochem., 20: 459, 1984.
16. Rose, D. P. and Connolly, J. M.: Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate, 18: 243, 1991.
17. Fang, J. L., Vaca, C. E., Valsta, L. M. and Mutanen, G.: Determination of DNA adduct of malondialdehyde in humans: effects of dietary fatty acid composition. Carcinogenesis, 17: 1035, 1996.
18. Clark, L. C., Coombs, D. F. and Turnbull, B. W.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA, 267: 1957, 1996.
19. Giovannucci, E., Acherio, A. and Rimm, E. B.: Intake of carotenoids and retinol in relation to prostate cancer risk. JNCI, 87: 1767, 1995.
20. Ripple, M. O., Henry, W. F., Rago, R. P. and Wilding, G.: Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma lines. JNCI, 89: 40, 1997.